|
GSK484,可逆的PAD4抑制剂
|
G276185-50mg
|
≥98% |
1652591-81-5 |
50mg
|
¥ 8341.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK484,可逆的PAD4抑制剂
|
G276185-25mg
|
≥98% |
1652591-81-5 |
25mg
|
¥ 5560.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK484,可逆的PAD4抑制剂
|
G276185-10mg
|
≥98% |
1652591-81-5 |
10mg
|
¥ 3015.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK2656157,PERK抑制剂
|
G276179-50mg
|
Moligand™, ≥98% |
1337532-29-2 |
50mg
|
¥ 2205.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK2656157,PERK抑制剂
|
G276179-250mg
|
Moligand™, ≥98% |
1337532-29-2 |
250mg
|
¥ 6117.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK2656157,PERK抑制剂
|
G276179-100mg
|
Moligand™, ≥98% |
1337532-29-2 |
100mg
|
¥ 3521.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK-J4,细组蛋白脱甲基酶JMJD3 / UTX抑制剂
|
G276086-5mg
|
Moligand™, ≥98% |
1373423-53-0 |
5mg
|
¥ 453.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK-J4,细组蛋白脱甲基酶JMJD3 / UTX抑制剂
|
G276086-25mg
|
Moligand™, ≥98% |
1373423-53-0 |
25mg
|
¥ 1445.9
|
现货 |
|
0 |
阿拉丁 |
|
GSK-J4,细组蛋白脱甲基酶JMJD3 / UTX抑制剂
|
G276086-100mg
|
Moligand™, ≥98% |
1373423-53-0 |
100mg
|
¥ 3466.9
|
现货 |
|
0 |
阿拉丁 |
|
人参皂甙Rg3
|
G275332-100mg
|
≥98% |
38243-03-7 |
100mg
|
¥ 2199.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
GYY 4137,水溶性,缓释H 2 S供体
|
G275260-500mg
|
≥95% |
106740-09-4 |
500mg
|
¥ 7699.9
|
现货 |
|
0 |
阿拉丁 |
|
GYY 4137,水溶性,缓释H 2 S供体
|
G275260-100mg
|
≥95% |
106740-09-4 |
100mg
|
¥ 2199.9
|
现货 |
|
0 |
阿拉丁 |
|
20(R)-人参皂甙Rh2
|
G274995-100mg
|
≥98% |
112246-15-8 |
100mg
|
¥ 1046.9
|
现货 |
|
0 |
阿拉丁 |
|
GR 46611,5-HT 1B / 1D激动剂
|
G274929-250mg
|
≥97% |
185259-85-2 |
250mg
|
¥ 9268.9
|
现货 |
|
0 |
阿拉丁 |
|
GR 46611,5-HT 1B / 1D激动剂
|
G274929-100mg
|
≥97% |
185259-85-2 |
100mg
|
¥ 4633.9
|
现货 |
|
0 |
阿拉丁 |
|
N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
|
G139266-5mg
|
Moligand™, ≥97% |
778277-15-9 |
5mg
|
¥ 184.9
|
现货 |
|
0 |
阿拉丁 |
|
N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
|
G139266-50mg
|
Moligand™, ≥97% |
778277-15-9 |
50mg
|
¥ 366.9
|
现货 |
|
0 |
阿拉丁 |
|
N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
|
G139266-25mg
|
Moligand™, ≥97% |
778277-15-9 |
25mg
|
¥ 274.9
|
现货 |
|
0 |
阿拉丁 |
|
N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
|
G139266-200mg
|
Moligand™, ≥97% |
778277-15-9 |
200mg
|
¥ 1386.9
|
现货 |
|
0 |
阿拉丁 |
|
N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
|
G139266-100mg
|
Moligand™, ≥97% |
778277-15-9 |
100mg
|
¥ 696.9
|
现货 |
|
0 |
阿拉丁 |
|
GW501516,PPARδ激动剂
|
G129772-1g
|
Moligand™, ≥97% |
317318-70-0 |
1g
|
¥ 1714.9
|
现货 |
|
0 |
阿拉丁 |
|
GW791343 三盐酸盐
|
G129554-5mg
|
≥98% |
309712-55-8 |
5mg
|
¥ 490.9
|
现货 |
|
0 |
阿拉丁 |
|
GW791343 三盐酸盐
|
G129554-25mg
|
≥98% |
309712-55-8 |
25mg
|
¥ 1544.9
|
现货 |
|
0 |
阿拉丁 |
|
GW791343 三盐酸盐
|
G129554-100mg
|
≥98% |
309712-55-8 |
100mg
|
¥ 4325.9
|
现货 |
|
0 |
阿拉丁 |